TCRX
Tscan Therapeutics Inc
0.3335$
+0.8%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
Tscan Therapeutics Inc (TCRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -135 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -13 | -3.0 | -49 | -67 | -61 | -111 | -135 | |
| 0.5 | 1.2 | 3.3 | 5.1 | 5.4 | 4.1 | 2.9 | |
| 0.2 | 0.5 | 2.5 | 4.6 | 5.2 | 9.5 | 12 | |
| 0.3 | 0.5 | 2.5 | 4.6 | – | – | – | |
| 0.3 | 21 | -5.9 | -10 | 18 | 5.1 | -18 | |
| 1.2 | 4.2 | 9.9 | 4.2 | 3.1 | 3.8 | 4.4 | |
| -1.2 | -4.2 | -9.9 | -4.2 | -61 | -53 | 109 | |
| – | – | – | – | – | 0.0 | 0.0 | |
| – | – | 190 | 0.3 | – | – | 0.3 | |
| 29 | 29 | 29 | 29 | 0.0 | 15 | 0.0 | |
| 35 | 0.3 | 190 | 29 | 135 | 209 | -0.3 | |
| 21 | -7.0 | 131 | -41 | 13 | 45 | -26 | |
| -14 | -7.3 | -59 | -71 | -65 | -115 | -140 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.